The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.
Shaked Lev-AriMichael SerzanTianmin WuAndrew IpLauren PascualBrittany SinclaireShari AdamsMichael MarafeliasLakshmi AyyagariSarvarinder K GillBarbara MaJacob P ZaemesAlexandra Della PiaAdil AlaouiSubha MadhavanAnas BeloualiAndrew PecoraJaeil AhnMichael B AtkinsNeil J ShahPublished in: Cancer (2023)
These findings in patients with melanoma who were treated with ICIs suggest that the use of SSs or ISAs for the management of irAEs is not associated with inferior disease outcomes, which supports the use of these agents when necessary.